GLP-1 Agonists and SGLT2 Inhibitors in HF Treatment GLP-1 Agonists and SGLT2 Inhibitors in HF Treatment

Although study results have been postive, particularly for SGLT2 inhibitors, questions still need to be answered about how these agents fit into treatment for heart failure.American College of Cardiology & Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Commentary Source Type: news